Missense Mutations in Exons 18–24 of EGFR in Hepatocellular Carcinoma Tissues

Table 2

Clinicopathological features of HCC patients which their tissue were determined by IHC.

Patients ()	(%)
Age (years)
<50	19 (47.5)
≥50	21 (52.5)
Range	35–94
Mean	51.6
Median	50.5
Sex
Male	35 (87.5)
Female	5 (12.5)
HBsAg
Negative	11 (27.5)
Positive	29 (72.5)
AFP
<500 ng/mL	24 (60)
≥500 ng/mL	14 (35)
Unknown	2 (5)
Tumor size
<5 cm	13 (32.5)
≥5 cm	27 (67.5)
TP53 expression
Negative	20 (50)
Positive	20 (50)
Ki-67 expression
Negative (10%)	9 (22.5)
Positive (≥10%)	31 (77.5)

HBsAg: hepatitis B surface antigen; AFP: alpha-fetoprotein; HCC: hepatocellular carcinoma; TP53: tumor protein p53.